Company / Current Assets per Share
Halozyme Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$6.70
FY2025
5-year range
$5.37 / $8.56
FY2021-FY2025
Trend
-21.7%
vs FY2024
Sector context
#110 of 210
Health Care
What the data says
At $6.70, Halozyme's current assets per share ranks #110 of 210 in the Health Care sector. Current Assets per Share has fluctuated over the past 10 years, ranging from $2.00 in FY2016 to $8.56 in FY2024.
Based on SEC 10-K filings.
6.70 in FY2025 with a 5-year CAGR of +10.6%.
Improved from $5.52 to $6.70 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- +7.6%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
#110 of 210 in Health CareTop 52% of 210This company $6.70 Sector average $134.38
▼
-95.0% below sector average
Key checks
Key Insights
- In FY2025, current assets per share decreased 21.7% year-over-year.
- Ranks #110 out of 210 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2024.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 47.9%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 118.2%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.70 | -21.7% |
| FY2024 | $8.56 | +55.0% |
| FY2023 | $5.52 | +2.8% |
| FY2022 | $5.37 | -21.6% |
| FY2021 | $6.86 | +69.1% |
| FY2020 | $4.06 | +8.1% |
| FY2019 | $3.75 | +25.3% |
| FY2018 | $3.00 | -24.0% |
| FY2017 | $3.94 | +96.9% |
| FY2016 | $2.00 | +46.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026